European Heart Journal Advance Access published online on May 22, 2006
European Heart Journal, doi:10.1093/eurheartj/ehl042
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
* To whom correspondence should be addressed. Aims Unstable coronary atherosclerotic plaque can be present in patients with chronic stable coronary artery disease (CAD). Our objective was to assess whether measurement of plasma pregnancy-associated plasma protein (PAPP-A) level, a reflection of plaque instability, in patients with chronic stable CAD had an independent prognostic value on the subsequent incidence of death, acute coronary syndrome (ACS), and revascularization. Methods and results Patients referred for coronary angiography were recruited. A cohort of 103 patients with stable symptoms for at least 6 weeks and with a coronary angiogram showing at least a 50% luminal diameter narrowing formed our study population. Median follow-up was 4.9 years. Mean age was 65 ± 10 years. In a multivariable model that included CAD traditional risk factors, ejection fraction, extent of coronary atherosclerosis, prior history of myocardial infarction, prior revascularization, discharge medications, and C-reactive protein, the plasma PAPP-A was found to be significantly associated with the endpoint of future death [adjusted hazard ratio (HR) 5.29; 95% CI 1.27-22.0; P = 0.023] and with the endpoint of future death and ACS (adjusted HR 3.56; 95% CI 1.27-10.0; P = 0.015), but not with the endpoint of future death and revascularization. Conclusion Measurement of plasma PAPP-A level in patients with chronic stable CAD has an independent prognostic value on the occurrence of death and ACS.
Received December 20, 2005
Revised March 16, 2006
Accepted May 4, 2006
Clinical research
Prognostic value of circulating pregnancy-associated plasma protein levels in patients with chronic stable angina
Ahmad A. Elesber 1,
Cheryl A. Conover 2,
Ali E. Denktas 1,
Ryan J. Lennon 3,
David R. Holmes Jr 1,
Michael T. Overgaard 4,
Michael Christiansen 5,
Claus Oxvig 4,
Lilach O. Lerman 6,
and
Amir Lerman 1 *
2 Endocrine Research Unit, Mayo Clinic College of Medicine, Rochester, MN, USA
3 Division of Biostatistics, Mayo Clinic College of Medicine, Rochester, MN, USA
4 Department of Molecular Biology, University of Aarhus, Aarhus, Denmark
5 Department of Clinical Biochemistry, Statens Serum Institute, Copenhagen, Denmark
6 Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA; Division of Nephrology and Hypertension, Mayo Clinic College of Medicine, Rochester, MN, USA
Amir Lerman, E-mail: lerman.amir{at}mayo.edu
Abstract 
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C. Etter, Y. Straub, M. Hersberger, H. R. Raz, T. Kistler, D. Kiss, R. P. Wuthrich, H.-J. Gloor, D. Aerne, P. Wahl, et al. Pregnancy-associated plasma protein-A is an independent short-time predictor of mortality in patients on maintenance haemodialysis Eur. Heart J., October 21, 2009; (2009) ehp429v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Martin, D. Gunnell, E. Whitley, A. Nicolaides, M. Griffin, N. Georgiou, G. Davey Smith, S. Ebrahim, and J. M. P. Holly Associations of Insulin-Like Growth Factor (IGF)-I, IGF-II, IGF Binding Protein (IGFBP)-2 and IGFBP-3 with Ultrasound Measures of Atherosclerosis and Plaque Stability in an Older Adult Population J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1331 - 1338. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Koenig and N. Khuseyinova Biomarkers of Atherosclerotic Plaque Instability and Rupture Arterioscler Thromb Vasc Biol, January 1, 2007; 27(1): 15 - 26. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Kaski and D. W. Holt Pregnancy-associated plasma protein-A and cardiovascular risk Eur. Heart J., July 2, 2006; 27(14): 1637 - 1639. [Full Text] [PDF]
|
|